| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 05/27/2004 | CA2505861A1 Pharmaceutical compositions and dosage forms for buccal and sublingual delivery of tizanidine and methods of administering tizanidine sublingually or bucally |
| 05/27/2004 | CA2505810A1 Stable aerosol formulation of peptides and protein with non-cfc propellants |
| 05/27/2004 | CA2505414A1 Lipophilic phosphoramide compounds and uses thereof |
| 05/27/2004 | CA2505126A1 Soluble oral patch with collagen and interlaced active ingredients |
| 05/27/2004 | CA2504956A1 Botulinum toxin formulations for oral administration |
| 05/27/2004 | CA2504608A1 Controlled release depot formulations |
| 05/27/2004 | CA2504605A1 Treatment of chronic lymphocytic leukemia and prostate cancer with microrna mir15 |
| 05/27/2004 | CA2504480A1 An acqueous pharmaceutical formulation comprising the thrombin inhibitor melagatran and use of the formulation in the manufacture of a medicament for use by nasal administration in treating thromboembolism |
| 05/27/2004 | CA2504200A1 The use of an anti-allergy agent and a steroid to treat allergic rhinitis |
| 05/27/2004 | CA2504197A1 Topical parasiticide formulations and methods of treatment |
| 05/27/2004 | CA2503644A1 Dietary supplement comprising parthenolide |
| 05/27/2004 | CA2503641A1 Compositions and methods of treatment to alleviate or prevent migrainous headaches and their associated symptoms |
| 05/27/2004 | CA2503630A1 Improved formulations containing substituted imidazole derivatives |
| 05/27/2004 | CA2502427A1 Combination product for controlling insect pests |
| 05/27/2004 | CA2501932A1 Use of benzimidazole quinolinones for treating cancer |
| 05/27/2004 | CA2497401A1 Chewing gum and confectionary compositions with encapsulated stain removing agent compositions, and methods of making and using the same |
| 05/27/2004 | CA2497268A1 Buccal, polar and non-polar spray or capsule containing drugs for treating pain |
| 05/26/2004 | EP1422292A1 Fermentation product of cyptoporus volvatus and its preparation method and use |
| 05/26/2004 | EP1422278A1 Pressure-sensitive adhesive sheet for medical use and process for producing the same |
| 05/26/2004 | EP1421990A1 Method for stabilizing active components using polyol/polymer microcapsule, and cosmetic composition containing the microcapsule |
| 05/26/2004 | EP1421989A1 Microcapsule and production method thereof |
| 05/26/2004 | EP1421974A1 Carboxy methyl beta-1, 3 glucan containing ophthalmic solution |
| 05/26/2004 | EP1421955A1 Percutaneous absorption preparations |
| 05/26/2004 | EP1421954A1 Materials sustainedly releasing drug in vivo |
| 05/26/2004 | EP1421944A1 Antacid and laxative tablets |
| 05/26/2004 | EP1421939A1 Sustained release preparation of a macrolide compound like tacrolimus |
| 05/26/2004 | EP1421932A1 Polyacrylic film forming compositions |
| 05/26/2004 | EP1421172A2 Artificial synapse chip interface for electronic prosthetic retina |
| 05/26/2004 | EP1421170A2 Therapeutic delivery compositions and methods of use thereof |
| 05/26/2004 | EP1421168A1 Concentrated stock of capsules for detergent or personal care compositions |
| 05/26/2004 | EP1421120A1 Hyperbranched amylopectin for use in methods for surgical or therapeutic treatment of mammals or in diagnostic methods, especially for use as a plasma volume expander |
| 05/26/2004 | EP1421115A2 Soluble t cell receptor |
| 05/26/2004 | EP1421093A1 Crystaline clindamycin free base |
| 05/26/2004 | EP1421032A1 Compositions comprising rigid-rod polymers and carbon nanotubes and process for making the same |
| 05/26/2004 | EP1420880A2 Stabilization and terminal sterilization of phospholipid formulations |
| 05/26/2004 | EP1420851A1 Use of a blood-flow decrease preventing agent in conjunction with insufflating gas |
| 05/26/2004 | EP1420831A1 Lipid constructs as therapeutic and imaging agents |
| 05/26/2004 | EP1420829A2 Immunomodulatory compositions, formulations, and methods for use thereof |
| 05/26/2004 | EP1420828A2 Lipophilic drug compositions |
| 05/26/2004 | EP1420827A1 5-cnac as oral delivery agent for parathyroid hormone fragments |
| 05/26/2004 | EP1420823A2 Immunogenic compositions containing antigens, gene vectors and adjuvants-loaded biodegradable microspheres |
| 05/26/2004 | EP1420818A1 Antigenic compositions |
| 05/26/2004 | EP1420802A1 Increased solubility flavanolignan preparations |
| 05/26/2004 | EP1420801A1 Use of fucans in the treatment of adhesions, arthritis and psoriasis |
| 05/26/2004 | EP1420798A2 Treatment and prevention of heat shock protein-associated diseases and conditions |
| 05/26/2004 | EP1420797A1 Dermal therapy using phosphate derivatives of electron transfer agents |
| 05/26/2004 | EP1420795A1 As-needed administration of an androgenic agent to enhance female sexual desire and responsiveness |
| 05/26/2004 | EP1420787A2 Ophthalmic composition comprising an ascomycin |
| 05/26/2004 | EP1420783A1 Stable emulsion composition |
| 05/26/2004 | EP1420777A2 Pharmaceutical compositions containing beta-lapachone, or derivatives or analogs thereof, and methods of using same |
| 05/26/2004 | EP1420775A1 Platinum complexes and their use in cancer treatment |
| 05/26/2004 | EP1420768A2 Methods and compositions for regulating memory consolidation |
| 05/26/2004 | EP1420767A1 Compositions containing itraconazole and their preparation methods |
| 05/26/2004 | EP1420766A1 Bilayered dispersible tablet formulation comprising amoxycillin and clavulanate in separate layers |
| 05/26/2004 | EP1420765A1 Injection molding process for the preparation of an oral delivery device for a pharmaceutically active agent |
| 05/26/2004 | EP1420763A1 Stable pharmaceutical compositions comprising acid labile benzimidazoles |
| 05/26/2004 | EP1420762A1 Residual solvant extraction method and microparticles produced thereby |
| 05/26/2004 | EP1420760A2 Aerosolized decongestants for the treatment of sinusitis |
| 05/26/2004 | EP1420759A2 Pharmaceutical compositions for the treatment of asthma |
| 05/26/2004 | EP1420716A1 An implantable and sealable system for unidirectional delivery of therapeutic agents to targeted tissues |
| 05/26/2004 | EP1420645A1 Multivesicular emulsion topical delivery systems |
| 05/26/2004 | EP1420643A2 Enhancement of transfection of dna into the liver |
| 05/26/2004 | EP1299095B1 Clear aqueous anaesthetic composition |
| 05/26/2004 | EP1265612B1 Pharmaceutical composition comprising pemetrexed together with monothioglycerol, l-cystein or thioglycolic acid |
| 05/26/2004 | EP1251827B1 Nasally administrable antifungal cyclic peptide compositions |
| 05/26/2004 | EP1216034B1 Method and device for dispensing adhesive laminate segments from a movable primary support sheet situated on a secondary support sheet |
| 05/26/2004 | EP1206258B1 Compositions containing esters for treating parasitic infestations of organisms |
| 05/26/2004 | EP1173176B1 Utilization of polycyclic 2-amino-thiazole systems in the production of medicaments for prophylaxis or treatment of obesity |
| 05/26/2004 | EP1165074B1 Viral treatment |
| 05/26/2004 | EP1161226B1 Phosphocholine linked prodrug derivatives |
| 05/26/2004 | EP1149057B1 Biodegradable glass compositions and their use in the manufacture of a medicament for radiation therapy |
| 05/26/2004 | EP1131050B1 Galenic formulations fast disintegrating in the mouth and method for preparing same |
| 05/26/2004 | EP1071398B1 Implants for administering substances and methods of producing implants |
| 05/26/2004 | EP1069885B1 Ophthalmic solution comprising glycogen |
| 05/26/2004 | EP1067910B1 Controlled release composition |
| 05/26/2004 | EP1059941B1 Pharmaceutical compositions and their use |
| 05/26/2004 | EP0971694B1 Drug preparations for treating sexual dysfunction |
| 05/26/2004 | EP0955058B1 Lactoferrin tablets |
| 05/26/2004 | EP0941068B1 Controlled release microspheres |
| 05/26/2004 | EP0932410B1 Mistletoe (viscum) extracts |
| 05/26/2004 | EP0915819B1 Illudin analogs useful as antitumor agents |
| 05/26/2004 | EP0894129B1 Short external guide sequences |
| 05/26/2004 | EP0888141B1 Film-forming compositions of antihyperalgesic opiates and their use for treating hyperalgesic conditions therewith |
| 05/26/2004 | EP0863745B1 Thermosensitive biodegradable polymers based on poly(ether-ester) block copolymers |
| 05/26/2004 | EP0778768B1 Formulations and methods for providing prolonged local anesthesia |
| 05/26/2004 | EP0740650B1 Codrugs as a method of controlled drug delivery |
| 05/26/2004 | CN2617363Y Quick soluble fragrant pills for shower bath |
| 05/26/2004 | CN2617362Y Suppository for vagina medicine feed |
| 05/26/2004 | CN1499985A Articles comprising mint odor-free cooling agent |
| 05/26/2004 | CN1499977A Compsns. and method of tissue superoxygenation |
| 05/26/2004 | CN1499968A Method of treatment of dopamine-related dysfuction |
| 05/26/2004 | CN1499962A Adhesive patch |
| 05/26/2004 | CN1499961A Pharmaceutical tablet system that floats on gastric fluid for multipulse release of active substance and respective processes of producing same and cup-shaped envelope of same |
| 05/26/2004 | CN1499960A Chornotherapeutic dosage forms |
| 05/26/2004 | CN1499959A Pharmaceutical compsn. comprising poorly water-soluble active ingredient, surfactant and water-soluble polymer |
| 05/26/2004 | CN1499958A Medical aerosol formulations |
| 05/26/2004 | CN1499933A Improved anti-inflammatory herbal compsn. and method of use |
| 05/26/2004 | CN1499930A Antifungal compsn. with enhanced bioavailability |
| 05/26/2004 | CN1499929A Formulations comprising entrapped active ingredients and uses thereof |
| 05/26/2004 | CN1499926A Improved pullulan free edible film compsns. and methods of making same |